Evaluation of baseline Cd4+ T lymphocytes as a predictors of clinical response to rituximab in patients with rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 23 Jul 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 23 Jul 2015 New trial record